HCmed Innovations Co., Ltd. (6934.TW)
Taiwan · TWD · Healthcare · Medical Devices
NT$81.80 (-4.33%) as of
Key statistics
- Market cap
- 2.96B
- EPS (TTM)
- -3.39
- Dividend yield
- 0.00%
- 52-week range
- 61.60 – 175.00
- Beta
- 1.49
- Revenue (TTM)
- 109.19M
- Profit margin
- -114.12%
- Analyst target
- NT$115.00
- Volume
- 27.31k
About HCmed Innovations Co., Ltd.
HCmed Innovations Co., Ltd. designs, develops, manufactures, and sells respiratory drug delivery systems in the United States, Europe, Africa, and Asia. The company's products include Pulmogine, a vibrating mesh nebulizer to nebulize a range of liquid medications to treat respiratory diseases and their symptoms in children and adults; and AdheResp, a breath-actuated mesh nebulizer for consumers and healthcare professionals. It also provides intellectual property, advanced technology, customization platforms, manufacturing and commercialization, and APSD analytical services. The company was founded in 2014 and is headquartered in Taipei, Taiwan.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Taipei, Taiwan
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.